| Name | Title | Contact Details |
|---|---|---|
Allan Badulis |
Director, Sales and Strategic Planning | Profile |
Linea Aspesi |
Vice President of Human Resources for North America | Profile |
Linea Aspesi |
Vice President, Head of Human Resources and Office Management | Profile |
Amway is the world`s No. 1 direct selling business, according to the Direct Selling News Global 100. Established in 1959, with sales of $8.6 billion, Amway operates in more than 100 countries and territories. We manufacture and distribute 450+ consumer products that support health and well-being. More than 19,000 employees worldwide support millions of Amway Business Owners who sell Amway products. Headquartered in Ada, Michigan, Amway is a center of health, skincare and home product innovation and top-selling, global brands. In addition, we are a company committed to providing employees with challenging career opportunities, a comprehensive total rewards package, profit sharing, tuition assistance, product discounts and an award-winning wellness program.
TigerConnect is healthcare`s most widely adopted communication platform – uniquely modernizing care collaboration among doctors, nurses, patients, and care teams. TigerConnect is the only solution that combines a consumer-like user experience for text, video, and voice communication with the serious security, privacy, and clinical workflow requirements that today`s healthcare organizations demand. TigerConnect accelerates productivity, reduces costs, and improves patient outcomes. Trusted by more than 5,000 healthcare organizations, TigerConnect maintains 99.99% verifiable uptime and processes more than 10 million messages each day.
Martech Medical Products is a Harleysville, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Premise Corporation is a Farmington, CT-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Third Pole, Inc. is a US-based company developing next generation life-saving cardiopulmonary therapies. We are building on our team`s legacy in inhaled nitric oxide (NO), the current standard of care, to develop next generation life-saving heart and lung therapies.